Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

39 External Beam Radiation Therapy (EBRT) II-39 Side Effects of Radiotherapy II-39 Strategies to Enhance Radiation Treatment II-39 New Radiation Techniques II-39 Whole Pelvic Radiation Therapy (WPRT) II-40 New Radiation Devices II-40 Chemotherapy II-40 Risks Associated with Chemotherapy II-41 Surgical Procedures for Prostate Cancer II-41 Transurethral Resection of the Prostate (TURP) II-41 Prostatectomy and Lymph Node Dissection II-42 Radical Prostatectomy II-42 Cryosurgery II-43 Advantages of Cryosurgery II-43 Disadvantages of Cryosurgery II-43 Other Treatment Options II-43 Intensity Modulated Radiation Therapy (IMRT) II-43 Benefits of IMRT II-44 Drawbacks of IMRT II-44 Androgen Deprivation Therapy (ADT) II-44 High Dose Radiation (HDR) Monotherapy II-45 Drawbacks of HRD II-45 Choosing the Optimal Treatment Method II-45 Recurrent Prostate Cancer II-46 Recurrent Prostate Cancer Subsequent to Surgery II-46 Recurrent Prostate Cancer Subsequent to Radiation Therapy II-47 Hormone-Refractory Prostate Cancer (HRPC) II-47 Select Drugs in Advanced Development Stage for Hormone- Refractory Prostate Cancer II-47 Chemotherapy II-47 Taxotere(R) (Docetaxel) II-48 Bone Complication Treatments II-48 Bisphosphonate Drugs II-48 Doxazosin, a Cytotoxic Drug for Prostate Cancer II-49 Radiation Therapy II-49 Strategies to Enhance Recurrent Prostate Cancer Treatment II-49 Chemotherapy - New Regimens II-49 Phase I Clinical Trials II-50 Combination Therapy II-50 Gene Therapy II-50 Targeted Therapy II-50 Selective Endothelia A Receptor Antagonist - (SERA(TM)) II-51 Other Select Targeted Therapies II-52 Tyrosine Kinase Inhibitors II-52 Anti-Angiogenic Drugs II-52 Monoclonal Antibodies II-52 Vaccines II-52 Radioactive Monoclonal Antibodies II-52 5. Dr
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, announced ... University of Calgary in conjunction with co-authors from Kyoto ... validates the company,s ongoing clinical research using dermal sheath ... baldness. The paper entitled " Hair Follicle ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
(Date:12/19/2014)... Charm Sciences is pleased to announce ... of Aflatoxin M1 in raw commingled milk is the ... validation. The peer reviewed report of the validation by ... Agricultural and Fisheries Research (ILVO-T&V) has been published by ... the most toxic aflatoxin and a known carcinogen, can ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... PharmaVentures announced today that it was delighted ... US and Canada as Merck & Co) to secure its ... Nottingham and Roslin BioCentre, for the former MSD research facility ... working between MSD, the Scottish Life Sciences community and the ...
... 17, 2012  Cepheid (Nasdaq: CPHD ) today ... the position of Senior Vice President, Human Resources, effective ... Cepheid from Verigy, Inc., a wholly owned subsidiary of ... Vice President of Human Resources.  Prior to Verigy, Mr. ...
... from a Nobel Laureate. Find out how major discoveries ... policy, education, and research in other countries. The iBioSeminars ... online, on-demand, and for free. iBioSeminars ... biology seminars given by the world,s leading researchers. The ...
Cached Biology Technology:PharmaVentures Helps Secure Investor for Former MSD Research Site 2Cepheid Welcomes Senior Vice President of Human Resources 2iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists 2
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International ... has released a new series of digital telemetry ... toxicology researchers. M series, part of the PhysioTel™ ... the best possible physiologic data when incorporating functional ... functional endpoints to toxicology studies has evolved from ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... acne live on everyone,s skin, yet one in five people ... a lifetime. In a boon for teenagers everywhere, a ... Louis and the Los Angeles Biomedical Research Institute has discovered ... "good" strains that may protect the skin. ...
... in German . , On the way ... Karlsruher Institut fr Technologie, or KIT for short, in cooperation ... realized another important milestone: the second process stage of the ... entrained flow gasifier bioliq II was handed over for operation. ...
... make up ScienceWorksForU.S. today again called on Congress to ... spending that will result in drastic reductions in funding ... U.S. economy of reduced R&D under sequestration are significant ... over the next nine years and 200,000 fewer jobs ...
Cached Biology News:New study could explain why some people get zits and others don't 2New study could explain why some people get zits and others don't 3Bioliq pilot plant: Successful operation of high-pressure entrained flow gasification 2Bioliq pilot plant: Successful operation of high-pressure entrained flow gasification 3Sequester will have a devastating impact on america's research enterprise 2Sequester will have a devastating impact on america's research enterprise 3
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Mammals microRNA Microarray ...
... The LIBS-ELITE houses Ocean Optics LIBS2000+ ... Research Universal Platform (UP) Ablation Chamber to ... position control. The systems features include a ... and targeting functions, precise X-Y sample positioning, ...
...
... The Varian 500-MS LC Ion ... for high-throughput LC/MS analysis where sensitivity, ... Varian 500-MS provides a robust platform ... sensitivity, mass resolution, and mass stability ...
Biology Products: